top of page
shutterstock_2188657227.jpg

Our Science

We grow cancer and maintain cancer tumor cells to measure treatment response

Anti-Cancer Array's platform can take cancer tumor cells and grow them - from a week measuring a patient's treatment response to an indefinite period backing up biobanks around the USA.

​

Thanks to our technology, you can see 1 tumor cell turn into many over 8 days.  We treat growing live tumor cells in these micro-wells with various treatments and measure response.

tumorgrowth2.24.png

Proprietary kits

Our intellectual property includes kits that process tumor samples, and can rapidly be deployed to serve patients in our own lab or even partner labs around the globe.

AT the LAb

Needle Biopsy Capabilities

Anti-Cancer Array is one of the only - if not the only - labs that can grow viable cancer cells originating from a patient's needle biopsy.  This allows us to work with patients at almost any point in their cancer treatment journey.

Lab Worker

Standardized and customized microenvironments to grow tumor cells

At Anti-Cancer Array, we use our own proprietary microenvironments for cancer tumor cells to grow at scale.

​

Here you can see live tumor tissue growing by itself (above), and the effects of a treatment (below).  In this case, we see a significant response to this particular treatment.

nk92.png

Scalability

Both our proprietary microenvironments and tumor processing kits give us the ability to move beyond drug discovery partnerships and enables us to directly help patients, families and oncologists.

shutterstock_159655766.jpg

Combination and Immune Therapy Testing

Anti-Cancer Array can include a large number of combination treatments, as well as the ability to include immune therapies.  Ask your doctor about what combination and immune treatments can be included on your array.

Pipetting Samples

We're in Pre-Launch Phase

Contact us to find out more about the test, and to help coordinate tumor cell collection, shipping, and discuss results.

​

While Anti-Cancer Array has not received full marketing clearance from the FDA, we expect to receive marketing clearance and launch the test around May 15th, 2024.  Click below to pre-order the test.

bottom of page